Explore Our Library of Biomanufacturing Resources & Technical Data

Application Notes

Maintaining Viable Cell Count in Primary T Cells During Cell Washing Using Optibumin®

Retain and Protect Final Cell Product with Optibumin®, a Recombinant Human Serum Albumin (rHSA)

Blog

Albumin in Drug Delivery: Cancer’s Unexpected Achilles’ Heel

Evolving Challenges in Closed-System Biomanufacturing

How Regulatory Bodies Are Driving the Shift to Animal-Origin-Free Solutions in Cell Therapy and Vaccine Development

Innovative Solutions in Closed-System Biomanufacturing: Exploring the Tools and Technologies Driving Sterility and Efficiency

Optibumin vs Traditional Albumin: Comparing Performance in Cell Wash Applications

Scaling Innovation: How DiscGenics and InVitria are Leading the Future of Cell Therapy

Why Border Disruptions Threaten Blood-Derived Raw Materials—and What Biomanufacturers Can Do About It

Why Do Some Biologics Cross the Finish Line—While Others Crash and Burn?

Catalog

InVitria Product Catalog – 2025

Data Sheets

Optibumin 20 – Data Sheet

News

InVitria Launches Optibumin 25 rHSA

Posters

Better Cells, Better Outcomes: Improving CAR-T Manufacturing with Animal-Free Cryopreservation and Wash Solutions

SDS

Optibumin – Safety Data Sheet

White Papers

Emergence of Blood-Free Recombinant Human Albumin

Optimizing the Performance of LNP and Liposome Therapeutics with Blood-Free Recombinant Albumin